CymaBay Therapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

68,457

Value ($000)

1,617

Weight

0.0%

2019 Q4 - 2023 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	1,617	0.0%	68,457	12/31/2023
2023 Q3	11/14/2023	2,327	0.0%	156,053	9/30/2023
2023 Q2	8/11/2023	1,303	0.0%	118,966	6/30/2023
2023 Q1	5/16/2023	10,328	0.0%	1,184,423	3/31/2023
2022 Q4	2/14/2023	2,518	0.0%	401,668	12/31/2022
2022 Q3	11/14/2022	389	0.0%	111,284	9/30/2022
2022 Q1	5/16/2022	113	0.0%	36,418	3/31/2022
2021 Q4	2/14/2022	37	0.0%	10,845	12/31/2021
2021 Q2	8/11/2021	333	0.0%	76,433	6/30/2021
2021 Q1	5/17/2021	507	0.0%	111,629	3/31/2021
2020 Q4	2/16/2021	448	0.0%	78,123	12/31/2020
2020 Q2	8/14/2020	963	0.0%	275,877	6/30/2020
2020 Q1	5/15/2020	131	0.0%	88,715	3/31/2020
2019 Q4	2/14/2020	168	0.0%	85,895	12/31/2019